Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Rosuvastatin reverses hypertension-induced changes in the aorta structure and endothelium-dependent relaxation in rats through suppression of apoptosis and inflammation.

Lv Q, Wang Y, Li Y, Zhao L, Gong Y, Wang M, Wang M, Fu G, Zhang W.

J Cardiovasc Pharmacol. 2020 Mar 19. doi: 10.1097/FJC.0000000000000828. [Epub ahead of print]

PMID:
32205566
2.
3.

Preparation and Performance of a Low-Carbon Foam Material of Fly-Ash-Based Foamed Geopolymer for the Goaf Filling.

Su L, Fu G, Wang Y, Yao G, Zhang J, Xu X, Jia B.

Materials (Basel). 2020 Feb 12;13(4). pii: E841. doi: 10.3390/ma13040841.

4.

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

Wang M, Lv Q, Zhao L, Wang Y, Luan Y, Li Z, Fu G, Zhang W.

Exp Ther Med. 2020 Feb;19(2):871-882. doi: 10.3892/etm.2019.8312. Epub 2019 Dec 10.

5.

Investigation of the underlying hub genes and mechanisms of reperfusion injury in patients undergoing coronary artery bypass graft surgery by integrated bioinformatic analyses.

Shen Z, Lu J, Wei J, Zhao J, Wang M, Wang M, Shen X, Lü X, Zhou B, Zhao Y, Fu G.

Ann Transl Med. 2019 Nov;7(22):664. doi: 10.21037/atm.2019.10.43.

6.

Identification of differentially expressed genes in the endothelial precursor cells of patients with type 2 diabetes mellitus by bioinformatics analysis.

Shen Z, Chen Q, Ying H, Ma Z, Bi X, Li X, Wang M, Jin C, Lai D, Zhao Y, Fu G.

Exp Ther Med. 2020 Jan;19(1):499-510. doi: 10.3892/etm.2019.8239. Epub 2019 Nov 22.

7.

Ticagrelor and clopidogrel suppress NF-κB signaling pathway to alleviate LPS-induced dysfunction in vein endothelial cells.

Jia Z, Huang Y, Ji X, Sun J, Fu G.

BMC Cardiovasc Disord. 2019 Dec 30;19(1):318. doi: 10.1186/s12872-019-01287-1.

8.

Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7.

Chen Q, Liu Y, Ding X, Li Q, Qiu F, Wang M, Shen Z, Zheng H, Fu G.

Mol Cell Biochem. 2020 Feb;465(1-2):103-114. doi: 10.1007/s11010-019-03671-z. Epub 2019 Dec 19.

9.

Early continuous ultrafiltration in Chinese patients with congestive heart failure (EUC-CHF): study protocol for an open-label registry-based prospective clinical trial.

Yang Y, Shen C, Lu J, Xu F, Tong J, Jiang J, Fu G.

BMC Cardiovasc Disord. 2019 Nov 7;19(1):249. doi: 10.1186/s12872-019-1208-y.

10.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

11.

A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.

Chen Y, Yin T, Xi S, Zhang S, Yan H, Tang Y, Qian J, Chen J, Su X, Du Z, Wang L, Qin Q, Gao C, Zheng Y, Zhao X, Cheng X, Li Z, Zhang W, Chen H, Wang J, Yang Z, Li H, Liu H, Zhou X, Qu B, Xiang D, Guo Y, Wang L, Nie S, Fu G, Yang M, Cai S.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1194-1204. doi: 10.1002/ccd.28325. Epub 2019 May 21.

PMID:
31112635
13.

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design.

Chen M, Wu S, Yao Y, Jiang J, Jiang C, Xue Y, Zhan X, Hu H, Fu G, Gu K, Liu H, Ding L, Jiang R, Chung FP, Lin YJ, Hori Y, Komatsu Y, Ueda A, Soejima K, Kim YH, Nogami A, Nakahara S, Chen SA, Tung R; PAUSE-SCD investigators.

J Interv Card Electrophysiol. 2020 Mar;57(2):271-278. doi: 10.1007/s10840-019-00535-w. Epub 2019 Mar 19.

PMID:
30891654
14.

Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.

Xu K, Fu G, Xu B, Zhou Y, Su X, Liu H, Zhang Z, Yu B, Wang X, Han Y; NeoVas OPC Investigators.

Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):832-838. doi: 10.1002/ccd.28067.

PMID:
30888736
15.

Theaflavin 3,3'-digallate reverses the downregulation of connexin 43 and autophagy induced by high glucose via AMPK activation in cardiomyocytes.

Shen Z, Chen Q, Jin T, Wang M, Ying H, Lu J, Wang M, Zhang W, Qiu F, Jin C, Zhao Y, Fu G.

J Cell Physiol. 2019 Aug;234(10):17999-18016. doi: 10.1002/jcp.28432. Epub 2019 Mar 7.

PMID:
30847932
16.

An expert recommendation on salt intake and blood pressure management in Chinese patients with hypertension: A statement of the Chinese Medical Association Hypertension Professional Committee.

Sun N, Mu J, Li Y; Working Committee of Salt evaluation, Blood Pressure Management, Chinese Medical Association Hypertension Professional Committee, Hypertension Group, Chinese Society of Cardiology.

J Clin Hypertens (Greenwich). 2019 Apr;21(4):446-450. doi: 10.1111/jch.13501. Epub 2019 Mar 3.

17.

Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.

Guo F, Sun Y, Wang X, Wang H, Wang J, Gong T, Chen X, Zhang P, Su L, Fu G, Su J, Yang S, Lai R, Jiang C, Liang P.

Circ Res. 2019 Jan 4;124(1):66-78. doi: 10.1161/CIRCRESAHA.118.313518.

PMID:
30582453
18.

Implantable cardioverter defibrillator replacement guided by T wave safety margin in a short QT syndrome patient.

Shen Y, Pan W, Jiang C, Fu G, Sun Y, Hu D.

Pacing Clin Electrophysiol. 2019 May;42(5):557-559. doi: 10.1111/pace.13580. Epub 2019 Jan 4.

PMID:
30548872
19.

Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.

Chen Y, Gao L, Qin Q, Chen S, Zhang J, Chen H, Wang L, Jin Z, Zheng Y, Zhang Z, Li H, Li X, Fu G, Chen L, Sun Z, Wang Y, Jin Q, Cao F, Guo J, Zhao Y, Guan C, Li W, Xu B; RESTORE ISR China Investigators.

JACC Cardiovasc Interv. 2018 Dec 10;11(23):2368-2377. doi: 10.1016/j.jcin.2018.09.010.

20.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574

Supplemental Content

Loading ...
Support Center